Cargando…
The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (20...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726277/ https://www.ncbi.nlm.nih.gov/pubmed/36482612 http://dx.doi.org/10.1097/MD.0000000000031639 |
_version_ | 1784844740520312832 |
---|---|
author | Lim, Dae Hyun Sohn, Won Jeong, Jae Yoon Oh, Hyunwoo Lee, Jae Gon Yoon, Eileen L. Kim, Tae Yeob Nam, Seungwoo Sohn, Joo Hyun |
author_facet | Lim, Dae Hyun Sohn, Won Jeong, Jae Yoon Oh, Hyunwoo Lee, Jae Gon Yoon, Eileen L. Kim, Tae Yeob Nam, Seungwoo Sohn, Joo Hyun |
author_sort | Lim, Dae Hyun |
collection | PubMed |
description | Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (2005–2019). We retrospectively collected data from 45,632 subjects who underwent anti-HAV IgG testing without evidence of acute HAV infection at four centers in the capital area of South Korea between January 2005 and December 2019. The seroprevalence of anti-HAV IgG was analyzed according to age and compared among seven age groups and five time periods. Additionally, age-period-cohort analyses were used to identify the age, period, and cohort effects of the seroprevalence of anti-HAV IgG. The mean age of the enrolled subjects was 39.2 ± 19.2 years, and the average anti-HAV IgG positivity rate was 66.4%. During the 15 years, the seroprevalence of anti-HAV IgG in people aged 0 to 19 years significantly increased over time (P < .001). In people aged 20 to 29 years, the seroprevalence slightly decreased to that of the early 2010s (31.3% in 2005–2007 to 19.7% in 2011–2013) but rebounded to 39.5% in 2017 to 2019. In contrast, the seroprevalence of anti-HAV IgG in those aged 30 to 49 years decreased over time (P < .001). The seroprevalence of anti-HAV IgG in those aged 20 to 39 years in 2017 to 2019 was still less than 40%. In addition, the seroprevalence of anti-HAV IgG in people aged 50 to 59 years has recently decreased. Since the introduction of the universal vaccination, the seroprevalence of anti-HAV IgG in children and young adults has gradually increased. However, the seroprevalence of anti-HAV IgG in people in their 20s remains low, and the seroprevalence of anti-HAV IgG in people in their 30s and 40s is gradually decreasing. Therefore, a new strategy for HAV vaccination is needed for those in their 20s to 40s. |
format | Online Article Text |
id | pubmed-9726277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-97262772022-12-09 The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea Lim, Dae Hyun Sohn, Won Jeong, Jae Yoon Oh, Hyunwoo Lee, Jae Gon Yoon, Eileen L. Kim, Tae Yeob Nam, Seungwoo Sohn, Joo Hyun Medicine (Baltimore) 4500 Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (2005–2019). We retrospectively collected data from 45,632 subjects who underwent anti-HAV IgG testing without evidence of acute HAV infection at four centers in the capital area of South Korea between January 2005 and December 2019. The seroprevalence of anti-HAV IgG was analyzed according to age and compared among seven age groups and five time periods. Additionally, age-period-cohort analyses were used to identify the age, period, and cohort effects of the seroprevalence of anti-HAV IgG. The mean age of the enrolled subjects was 39.2 ± 19.2 years, and the average anti-HAV IgG positivity rate was 66.4%. During the 15 years, the seroprevalence of anti-HAV IgG in people aged 0 to 19 years significantly increased over time (P < .001). In people aged 20 to 29 years, the seroprevalence slightly decreased to that of the early 2010s (31.3% in 2005–2007 to 19.7% in 2011–2013) but rebounded to 39.5% in 2017 to 2019. In contrast, the seroprevalence of anti-HAV IgG in those aged 30 to 49 years decreased over time (P < .001). The seroprevalence of anti-HAV IgG in those aged 20 to 39 years in 2017 to 2019 was still less than 40%. In addition, the seroprevalence of anti-HAV IgG in people aged 50 to 59 years has recently decreased. Since the introduction of the universal vaccination, the seroprevalence of anti-HAV IgG in children and young adults has gradually increased. However, the seroprevalence of anti-HAV IgG in people in their 20s remains low, and the seroprevalence of anti-HAV IgG in people in their 30s and 40s is gradually decreasing. Therefore, a new strategy for HAV vaccination is needed for those in their 20s to 40s. Lippincott Williams & Wilkins 2022-12-02 /pmc/articles/PMC9726277/ /pubmed/36482612 http://dx.doi.org/10.1097/MD.0000000000031639 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 4500 Lim, Dae Hyun Sohn, Won Jeong, Jae Yoon Oh, Hyunwoo Lee, Jae Gon Yoon, Eileen L. Kim, Tae Yeob Nam, Seungwoo Sohn, Joo Hyun The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title | The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title_full | The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title_fullStr | The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title_full_unstemmed | The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title_short | The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea |
title_sort | chronological changes in the seroprevalence of anti-hepatitis a virus igg from 2005 to 2019: experience at four centers in the capital area of south korea |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726277/ https://www.ncbi.nlm.nih.gov/pubmed/36482612 http://dx.doi.org/10.1097/MD.0000000000031639 |
work_keys_str_mv | AT limdaehyun thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT sohnwon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT jeongjaeyoon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT ohhyunwoo thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT leejaegon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT yooneileenl thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT kimtaeyeob thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT namseungwoo thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT sohnjoohyun thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT limdaehyun chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT sohnwon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT jeongjaeyoon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT ohhyunwoo chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT leejaegon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT yooneileenl chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT kimtaeyeob chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT namseungwoo chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea AT sohnjoohyun chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea |